Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 826 participants.

Also called NCT04135677

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 826 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04135677
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04135677. Randomized; triple masking; primary purpose prevention. Start 2022-11-11 (actual); primary completion 2024-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO
Condition
Left Atrial Appendage Thrombosis
Condition
Thrombi
Condition
Stroke
Intervention (Drug)
Rivaroxaban
Intervention (Drug)
DAPT
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct04135677
Content hash
8595bf02c856529d3e3ee147ebf063adaacd61048630753f182a3cc589ffe2b4